Pharmessen

Pharmessen Scientific is a biotechnology company focused on the discovery and development of natural product-based therapeutics and high-quality nutraceuticals. The company specializes in metabolic health, particularly targeting indications such as type 2 diabetes and obesity through the development of GLP-1 receptor agonists and DPP-4 inhibitors derived from botanical sources. Pharmessen provides a range of specialized ingredients and finished products to the global healthcare market, leveraging its expertise in phytochemistry and molecular biology. Their business model encompasses both the commercialization of proprietary health supplements and the research of novel bioactive compounds for pharmaceutical applications.